Early research (Phase 1)Looking for participantsNCT07774572What this trial is testingExploration of Circular RNA in B-cell Hematologic MalignanciesWho this might be right forLymphoma, B-Cell Refractory Ruijin Hospital 30
Early research (Phase 1)Ended earlyNCT02454270What this trial is testingA Dose Escalation Study of Duvortuxizumab in Participants With Relapsed or Refractory B-cell MalignanciesWho this might be right forLeukemia, Lymphocytic, Chronic, B-CellLymphoma, Large B-Cell, DiffuseLymphoma, Follicular+2 more Janssen Research & Development, LLC 59
Testing effectiveness (Phase 2)Looking for participantsNCT06014073What this trial is testingTRAC and Power3 (SPPL3) Genes Knock-out Allogeneic CD19-targeting CAR-T Cell Therapy in r/r B-NHLWho this might be right forNon Hodgkin's Lymphoma Chinese PLA General Hospital 30
Not applicableLooking for participantsNCT06788639What this trial is testingPatients With Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Treated With Lisocabtagene Maraleucel in the Post-Marketing SettingWho this might be right forChronic Lymphocytic Leukemia (CLL)Small Lymphocytic Lymphoma (SLL) Juno Therapeutics, Inc., a Bristol-Myers Squibb Company 300
Testing effectiveness (Phase 2)Study completedNCT01427881What this trial is testingCyclophosphamide for Prevention of Graft-Versus-Host Disease After Allogeneic Peripheral Blood Stem Cell Transplantation in Patients With Hematological MalignanciesWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Megakaryoblastic Leukemia (M7)+65 more Fred Hutchinson Cancer Center 43
Testing effectiveness (Phase 2)Study completedNCT01980628What this trial is testingStudy of the Bruton's Tyrosine Kinase Inhibitor in Subjects With Relapsed/Refractory Marginal Zone LymphomaWho this might be right forMarginal Zone LymphomaB-cell Lymphoma Pharmacyclics LLC. 63
Testing effectiveness (Phase 2)UnknownNCT00740467What this trial is testingStem Cell Transplant in Treating Patients With Hematological Cancer or Other DisordersWho this might be right forGraft Versus Host DiseaseLeukemiaLymphoma+2 more Institut Paoli-Calmettes 50
Early research (Phase 1)WithdrawnNCT02238522What this trial is testingPhase 1 Study Evaluating ZEN003365 in Relapsed/Refractory Lymphoproliferative Malignancies or Relapsed/Refractory AMLWho this might be right forLymphoproliferative MalignanciesAcute Myeloid Leukemia Zenith Epigenetics
Testing effectiveness (Phase 2)Study completedNCT01965119What this trial is testingPilot Study of Ruxolitinib in Relapsed or Refractory Hodgkin Lymphoma and Primary Mediastinal Large B-cell LymphomaWho this might be right forRelapsed or Refractory Hodgkin LymphomaPrimary Mediastinal Large B-cell Lymphoma Samsung Medical Center 20
Testing effectiveness (Phase 2)Study completedNCT05459571What this trial is testingStudy of Axicabtagene Ciloleucel Given With Steroids In Participants With Relapsed Or Refractory Large B-Cell LymphomaWho this might be right forRelapsed or Refractory Large B-cell Lymphoma Kite, A Gilead Company 35
Testing effectiveness (Phase 2)Looking for participantsNCT04836507What this trial is testingStudy of Efficacy and Safety of CRC01 in Adult Large B-cell Lymphoma and B-cell Acute Lymphoblastic Leukemia PatientsWho this might be right forRelapsed Large B-cell LymphomaRefractory Large B-cell LymphomaDiffuse Large B-cell Lymphoma (DLBCL)+4 more Curocell Inc. 91
Testing effectiveness (Phase 2)Study completedNCT00005592What this trial is testingRadioimmunotherapy in Patients With Relapsed or Refractory Non-Hodgkin's LymphomaWho this might be right forLymphoma University of Alabama at Birmingham 23
Testing effectiveness (Phase 2)Study completedNCT00119392What this trial is testingYttrium Y 90 Ibritumomab Tiuxetan, Fludarabine, Radiation Therapy, and Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's LymphomaWho this might be right forB-cell Chronic Lymphocytic LeukemiaNodal Marginal Zone B-cell LymphomaRecurrent Adult Burkitt Lymphoma+14 more Fred Hutchinson Cancer Center 42
Early research (Phase 1)Study completedNCT00006098What this trial is testingPS-341 in Treating Patients With Hematologic CancerWho this might be right forLeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Ended earlyNCT04240704What this trial is testingSafety and Preliminary Efficacy of JBH492 Monotherapy in Patients With CLL and NHLWho this might be right forNon-Hodgkins LymphomaChronic Lymphocytic Leukemia Novartis Pharmaceuticals 25
Early research (Phase 1)UnknownNCT04814004What this trial is testingClinical Study of CAR-iNKT Cells in the Treatment of Relapsed/Refractory/High-risk B-cell TumorsWho this might be right forAcute Lymphoblastic LeukemiaB-cell LymphomaChronic Lymphocytic Leukemia Kai Lin Xu; Jun Nian Zheng 20
Large-scale testing (Phase 3)Looking for participantsNCT07139873What this trial is testingDZD8586 Versus Investigator's Choice in r/r CLL/SLL (TAI-SHAN6)Who this might be right forChronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Dizal Pharmaceuticals 250
Early research (Phase 1)UnknownNCT03281551What this trial is testingEfficacy and Safety of PZ01 Treatment in Patients With r/r CD19+ B-cell Acute Lymphoblastic Leukemia/B Cell LymphomaWho this might be right forB-cell Acute Lymphoblastic LeukemiaB-cell Lymphoma Pinze Lifetechnology Co. Ltd. 50
Testing effectiveness (Phase 2)Looking for participantsNCT04110301What this trial is testingMIL62 Plus Lenalidomide for Patients With Relapsed/Refractory Indolent Non-Hodgkin's Lymphoma (FL and MZL)Who this might be right forFollicular Lymphoma and Marginal Zone Lymphoma Beijing Mabworks Biotech Co., Ltd. 53
Large-scale testing (Phase 3)Looking for participantsNCT06792253What this trial is testingStudy Comparing BEBT-908 Combined With R to SOC for the Treatment of Relapsed/Refractory Diffuse Large B-Cell LymphomaWho this might be right forRelapsed/Refractory Diffuse Large B-Cell Lymphoma BeBetter Med Inc 416